UNSPSC 51393001: Quazinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H10ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D1Q7F6C2FP, chemically known as (r)-6-chloro-1,5-dihydro-3-methylimidazo(2,1-b)quinazolin-2(3h)-one but generally known as quazinone, which bears US NIH Compound Identifier 5000. European Medicines Agency schedules Quazinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10189MIG.

UNSPSC 51393001 Quazinone is a Commodity code under which state and local governments procure naloxone and drug deactivation systems to support public health and emergency response initiatives. The work involves supplying pharmaceutical products and related equipment designed for opioid overdose reversal and controlled drug disposal, typically through annual supply contracts with quarterly or as-needed deliveries to county health departments, community health facilities, or emergency services.

Seminole County, Florida recently issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a two-year initial term with one-year renewal option. The solicitation required vendors to provide unit costs for each line item, maintain workers' compensation and commercial general liability insurance, comply with drug-free workplace and E-Verify requirements, and absorb all shipping and delivery costs in their proposals. The code shows minimal recent activity in the available source material, with only one identified state or local opportunity; characterization of issuing-body patterns or geographic concentration across multiple jurisdictions is not supported by the data.